Company: SXTPW
Filing Date: 2025-08-27
Form Type: DEF 14A
Source: 0001213900-25-080878
Chunk: 41

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-08-27
Form: DEF 14A
Chunk 41
---
, and to promote the success of our business. The administrator of the 2022 Plan may, in its sole
discretion, amend, alter, suspend or terminate the 2022 Plan, or any part thereof, at any time and for any reason. Unless earlier terminated
by the administrator, the 2022 Plan will terminate ten years from the date it is adopted by our Board.

Overview and Purpose of the Stockholder Approval

In order to give the Company the flexibility to
responsibly address its future equity compensation needs, the Company is requesting that stockholders approve the Plan Amendment, which
will authorize an additional 250,000 shares for issuance under the 2022 Plan, so that an overall total of 465,452 shares will be reserved
under the 2022 Plan. Having a sufficient number of shares under the 2022 Plan is critical to our ability to continue to attract, retain,
engage and focus highly motivated and qualified employees, particularly in the competitive labor market that exists today in our industry.
A copy of the Plan Amendment is attached to this proxy statement as and a copy of the 2022 Plan is attached to this proxy
statement as .

No Appraisal Rights

Stockholders have no rights under the DGCL or
under our Certificate of Incorporation to exercise dissenters’ rights of appraisal with respect to the approval of the Plan Amendment.

Description of the 2022 Plan

The principal features of the 2022 Plan are summarized
below, but the below summary is qualified in its entirety by reference to the full text of the plan document.

Authorized Shares

Initially, the maximum
number of shares of our common stock that may be subject to awards under the 2022 Plan was equal to 3,977. The 2022 Plan provides for
an annual automatic increase in the number of shares available for issuance beginning on January 1, 2023, and each January 1 thereafter,
by four percent (4%) of the number of outstanding shares of common stock on the immediately preceding December 31, or such lesser number
of shares as determined by our Board. On July 16, 2024 and November 6, 2024, our stockholders approved an increase to the number of shares
available under the 2022 Plan by 83,334 shares and 100,000 shares, respectively, which increases were previously approved by the Board.
As of the Record Date, the maximum shares of our common stock that may be subject to awards under the 202